image
In response to national controversy over academic ghostwriting by pharmaceutical companies, DHMC plans to revise its policies to prohibit the practice.
In response to national controversy over academic ghostwriting by pharmaceutical companies, DHMC plans to revise its policies to prohibit the practice.